Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | HTR2A | P28223 | 1/20 | 0.67 |
| ▸ | HTR2C | P28335 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | NR2E1 | Q9Y466 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | HTR5A | P47898 | 1/20 | 0.59 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 1/20 | 0.53 |
| ▸ | DRD4 | P21917 | 1/20 | 0.53 |
| ▸ | DRD5 | P21918 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL481360 | 1.00 | KDM4E (0.68) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL104598 | 0.96 | KDM4E (0.73) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL30160092 | 0.96 | KDM4E (0.73) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL11641810 | 0.94 | SMN1; SMN2 (0.74) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| Bromide SCHEMBL8568783 | 0.94 | KDM4E (0.71) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| Iodide SCHEMBL8569085 | 0.94 | KDM4E (0.71) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL30657796 | 0.94 | SMN1; SMN2 (0.74) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL7402531 | 0.94 | KDM4E (0.71) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL14156164 | 0.94 | SMN1; SMN2 (0.74) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 | |
| SCHEMBL15266076 | 0.94 | KDM4E (0.71) | KDM4EALDH1A1HTR2AHTR2CSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060057-B | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119060057-A | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2024-12-03 | — | — | CN | claimed |
| CN-118373766-B | Asymmetric catalytic hydrogenation method of indolocyclopentenyl malonate and application thereof | 南开大学 | 2025-11-04 | — | — | CN | disclosed |
| CN-119060057-B | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119060057-B | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119060057-A | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2024-12-03 | — | — | CN | disclosed |
| CN-119060057-A | Indolocyclopentanes Compound and synthesis method thereof | 常州大学 | 2024-12-03 | — | — | CN | disclosed |
| CN-118373766-A | Asymmetric catalytic hydrogenation method of indolocyclopentenyl malonate and application thereof | 南开大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-118373766-A | Asymmetric catalytic hydrogenation method of indolocyclopentenyl malonate and application thereof | 南开大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-118290453-A | Light-emitting element and condensed polycyclic compound for light-emitting element | 三星显示有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20230272401-A1 | COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF | Genetic Intelligence, Inc | 2023-08-31 | — | — | US | disclosed |
| WO-2022192079-A1 | COMPOUNDS FOR PROTECTION OF NOISE-INDUCED HEARING-LOSS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230272401-A1 | COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF | TARDBP, FUS, RBM17 | KDM4E 2645/4885ALDH1A1 4065/4885HTR2A 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.